scholarly journals Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability

2016 ◽  
Vol Volume 10 ◽  
pp. 1913-1918 ◽  
Author(s):  
Ganesan Baranidharan ◽  
Muhammad Laklouk
Keyword(s):  
Neuropathic Pain ◽  
Postherpetic Neuralgia ◽  
Patient Acceptability

scholarly journals Neuralgias of the Trigeminal Nerve

2000 ◽  
Vol 5 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Allan S Gordon
Keyword(s):  
Neuropathic Pain ◽  
Differential Diagnosis ◽  
Trigeminal Neuralgia ◽  
Clinical Features ◽  
Trigeminal Nerve ◽  
Postherpetic Neuralgia ◽  
Facial Pain ◽  
The Other ◽  
Atypical Facial Pain ◽  
Trigeminal Neuropathic Pain

Practitioners are often presented with patients who complain bitterly of facial pain. The trigeminal nerve is involved in four conditions that are sometimes mixed up. The four conditions - trigeminal neuralgia, trigeminal neuropathic pain, postherpetic neuralgia and atypical facial pain - are discussed under the headings of clinical features, differential diagnosis, cause and treatment. This article should help practitioners to differentiate one from the other and to manage their care.

Postherpetic Neuralgia: A Patient’s and a Physician’s Perspective

2016 ◽  
Author(s):  
James H. Diaz
Keyword(s):  
Neuropathic Pain ◽  
Herpes Zoster ◽  
Postherpetic Neuralgia ◽  
Clinical Manifestations ◽  
The United States ◽  
Evidence Based ◽  
Pain Medicine ◽  
High Prevalence ◽  
Antiviral Medications ◽  
Physician’S Perspective

Herpes zoster can plague anyone who has had varicella or has received the varicella or chickenpox vaccine. The incidence of herpes zoster increases with age and rises exponentially after 60 years of age. Postherpetic neuralgia (PHN) may occur after herpes zoster at any age but typically occurs after 50 years of age, with over 40% of persons over 60 years of age suffering from PHN after a shingles attack. Up to 1 million new cases of herpes zoster and 200,000 new cases of PHN may now be anticipated in the United States every year, with the incidence rate increasing as the population grows and ages with prolonged life expectancies. Although new antiviral medications will improve and shorten the course of herpes zoster, they do not guarantee the prevention of PHN. Given the high prevalence of PHN in an aging population and the availability of primary prevention by vaccination, the objectives of this review are to describe the epidemiology, pathophysiology, and clinical manifestations of zoster and PHN and to recommend a combination of strategies for the clinical management and prevention of PHN. This review contains 6 figures, 4 tables and 13 references Key words: evidence-based pain medicine, herpes zoster, neuropathic pain, postherpetic neuralgia

Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin

2015 ◽  
Vol 173 (1) ◽  
pp. 300-302 ◽  
Author(s):  
S. Hiom ◽  
G.K. Patel ◽  
R.G. Newcombe ◽  
S. Khot ◽  
C. Martin
Keyword(s):  
Neuropathic Pain ◽  
Postherpetic Neuralgia ◽  
Pain Syndromes

Poster 129 Pain Relief and Its Impact on Sleep in Treatment of Neuropathic Pain Associated with Postherpetic Neuralgia

PM&R ◽  
2015 ◽  
Vol 7 ◽  
pp. S134-S134
Author(s):  
Mark S. Wallace ◽  
Brett B. Snodgrass ◽  
Jamie Massengill ◽  
Iwona Bucior ◽  
Charles Argoff
Keyword(s):  
Neuropathic Pain ◽  
Pain Relief ◽  
Postherpetic Neuralgia
Sign in / Sign up

Export Citation Format

Share Document